Literature DB >> 19556298

Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy.

Rachel Lennon1, Deborah Pons, Matthew A Sabin, Christina Wei, Julian P Shield, Richard J Coward, Jeremy M Tavaré, Peter W Mathieson, Moin A Saleem, Gavin I Welsh.   

Abstract

BACKGROUND: Cellular insulin resistance is the hallmark of type 2 diabetes and predominantly affects adipose and muscle cells. The saturated free fatty acid palmitate is elevated in insulin-resistant states and may directly contribute to cellular insulin resistance. A spectrum of renal disease is associated with increased markers of insulin resistance, although direct causal mechanisms are not known. In the kidney, glomerular podocytes are novel insulin-sensitive cells that have the ability to rapidly transport glucose. In this study, we tested the hypothesis that palmitate would induce insulin resistance in podocytes.
METHODS: Conditionally immortalized human podocytes were cultured for up to 24 h with 375-750 muM palmitate. Functional effects on glucose uptake and ceramide production were measured. Gene expression was investigated using a focused gene array, and protein signalling and trafficking were studied with Western blotting and immunofluorescence.
RESULTS: We found that palmitate blocked insulin-stimulated glucose uptake in human podocytes. This was associated with increased ceramide production, and use of the ceramide inhibitors myriocin and fumonisin B1 partially recovered the insulin sensitivity. At the level of transcription, palmitate downregulated genes associated with several pathways involved in insulin signalling. At the protein level, phosphorylation of the insulin receptor, IRS1 and PKB was reduced and there was impaired translocation of GLUT4 to the cell surface.
CONCLUSION: This is the first study to demonstrate a direct effect of saturated fatty acids on podocyte function. These findings may represent a novel link between systemic insulin resistance and the development of nephropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556298     DOI: 10.1093/ndt/gfp302

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  59 in total

Review 1.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Authors:  Jennifer H Stern; Joseph M Rutkowski; Philipp E Scherer
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

2.  Salivary extracellular RNA biomarkers for insulin resistance detection in hispanics.

Authors:  Yong Zhang; Jie Sun; Feng Li; Tristan R Grogan; Jose L Vergara; QingXian Luan; Moon-Soo Park; David Chia; David Elashoff; Kaumudi J Joshipura; David T W Wong
Journal:  Diabetes Res Clin Pract       Date:  2017-07-19       Impact factor: 5.602

3.  Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease.

Authors:  Jing Ma; Alla Karnovsky; Farsad Afshinnia; Janis Wigginton; Daniel J Rader; Loki Natarajan; Kumar Sharma; Anna C Porter; Mahboob Rahman; Jiang He; Lee Hamm; Tariq Shafi; Debbie Gipson; Crystal Gadegbeku; Harold Feldman; George Michailidis; Subramaniam Pennathur
Journal:  Bioinformatics       Date:  2019-09-15       Impact factor: 6.937

4.  MicroRNA-155 Mediates Obesity-Induced Renal Inflammation and Dysfunction.

Authors:  Chenfei Zheng; Ji Zhang; Xinxin Chen; Jianna Zhang; Xiaokai Ding; Xiaohan You; Lin Fan; Chaosheng Chen; Ying Zhou
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 5.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

6.  Adiponectin inhibits insulin function in primary trophoblasts by PPARα-mediated ceramide synthesis.

Authors:  Irving L M H Aye; Xiaoli Gao; Susan T Weintraub; Thomas Jansson; Theresa L Powell
Journal:  Mol Endocrinol       Date:  2014-02-25

7.  Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians.

Authors:  Farsad Afshinnia; Viji Nair; Jiahe Lin; Thekkelnaycke M Rajendiran; Tanu Soni; Jaeman Byun; Kumar Sharma; Patrice E Fort; Thomas W Gardner; Helen C Looker; Robert G Nelson; Frank C Brosius; Eva L Feldman; George Michailidis; Matthias Kretzler; Subramaniam Pennathur
Journal:  JCI Insight       Date:  2019-11-01

Review 8.  Lipotoxicity as a trigger factor of renal disease.

Authors:  Adriana Izquierdo-Lahuerta; Cristina Martínez-García; Gema Medina-Gómez
Journal:  J Nephrol       Date:  2016-03-08       Impact factor: 3.902

9.  Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1.

Authors:  R Lennon; G I Welsh; A Singh; S C Satchell; R J Coward; J M Tavaré; P W Mathieson; M A Saleem
Journal:  Diabetologia       Date:  2009-06-17       Impact factor: 10.122

10.  Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy.

Authors:  Ai-Li Cao; Li Wang; Xia Chen; Yun-Man Wang; Heng-Jiang Guo; Shuang Chu; Cheng Liu; Xue-Mei Zhang; Wen Peng
Journal:  Lab Invest       Date:  2016-03-21       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.